跳至主要内容
临床试验/NCT00992082
NCT00992082Unknown不适用

Local Infiltration Analgesia or Intrathecal Morphine in Total Knee Arthroplasty

Region Örebro County1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2009年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
50
试验地点
1
主要终点
Morphine consumption

研究概览

简要总结

The purpose of this study is to determine whether local infiltration analgesia is more effective than intrathecal morphine in reducing postoperative pain in total knee arthroplasty.

详细描述

Postoperative pain is often severe following total knee arthroplasty. Spinal anesthesia is a common method in total knee arthroplasty. Adding morphine to the local anesthetic injected intrathecally prolongs the analgetic effect, but may give the usual opioid side effects. The Local Infiltration Analgesia (LIA) technique has proven effective in reducing postoperative pain in total knee arthroplasty. In the LIA technique a long-acting local anesthetic (ropivacaine), a nonsteroidal anti-inflammatory drug (ketorolac), and epinephrine are infiltrated intraoperatively and via an intraarticular catheter postoperatively.

The aim of this study is to evaluate if spinal anesthesia together with the LIA technique provide better postoperative pain relief and mobilization than spinal anesthesia with addition of morphine to the local anesthetic intrathecally. Primary end-point is morphine consumption the first 48 postoperative hours. Secondary end-points are pain intensity, knee function, time to home readiness, hospital stay, side effects and patient satisfaction. Patients are followed up to 3 months after surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
40 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients scheduled for total knee arthroplasty under spinal anesthesia.
  • Aged 40-85 yrs.
  • ASA physical status I-III and mobility indicating normal postoperative mobilization.

排除标准

  • Known allergy or intolerance to one of the study drugs.
  • Serious liver-, heart- or renal decease.
  • Rheumatoid arthritis.
  • Chronic pain or bleeding disorder.

研究组 & 干预措施

Group LIA

Active Comparator

Local Infiltration Analgesia

干预措施: ropivacaine, ketorolac and epinephrine (Drug)

Group M

Active Comparator

Intrathecal morphine

干预措施: morphine (Drug)

结局指标

主要结局

Morphine consumption

时间窗: The first 48 postoperative hours

次要结局

  • Pain intensity(0-3 months)
  • Knee function(0-3 months)
  • Time to home readiness(0-2 weeks)
  • Hospital stay(0-2 weeks)
  • Side effects(0-3 months)
  • Patient satisfaction(0-3 months)

研究者

发起方
Region Örebro County
申办方类型
Other

研究点 (1)

Loading locations...

相似试验